Skip to main content

Table 3 Coronary heart disease risk parameter changes during the weight loss period 1

From: Intermittent fasting combined with calorie restriction is effective for weight loss and cardio-protection in obese women

  

IFCR-L

  

IFCR-F

 
 

Week 3

Week 10

Change2

Week 3

Week 10

Change2

Systolic BP (mm Hg)

120 ± 3

118 ± 2

−2 ± 6

116 ± 4

114 ± 2

−2 ± 4

Diastolic BP (mm Hg)

83 ± 3

79 ± 3

−4 ± 4

80 ± 3

80 ± 2

0 ± 3

Heart rate (bpm)

73 ± 3

70 ± 4 3

−3 ± 4 4

78 ± 2

81 ± 2

3 ± 2

Glucose (mg/dl)

120 ± 2

116 ± 2 3

−4 ± 3

120 ± 3

117 ± 3

−3 ± 4

Insulin (uIU/ml)

14 ± 1

11 ± 1 3

−3 ± 3

15 ± 2

13 ± 2

−2 ± 2

C-Reactive protein (mg/dl)

0.4 ± 0.1

0.4 ± 0.1

0 ± 0.1

0.6 ± 0.2

0.4 ± 0.1

−0.2 ± 0.2

Homocysteine (ng/dl)

10 ± 1

8 ± 1 3

−2 ± 1 4

10 ± 1

10 ± 1

0 ± 1

Adiponectin (ng/ml)

7893 ± 1002

5462 ± 576 3

−2431 ± 802

8442 ± 1201

5931 ± 964 3

−2511 ± 771

Leptin (ng/ml)

37 ± 3

27 ± 3 3

−10 ± 2

38 ± 2

29 ± 2 3

−9 ± 2

  1. 1 Values reported as mean ± SEM. IFCR-L: Intermittent fasting calorie restriction-liquid diet (n = 28); IFCR-F: Intermittent fasting calorie restriction-food based diet (n = 26); BP: Blood pressure.
  2. 2 Change expressed as the difference between week 3 and week 10 absolute values.
  3. 3 Week 3 values significantly (P < 0.05) different from week 10 values within group (Repeated-measures ANOVA).
  4. 4 Absolute change significantly different (P < 0.05) between the IFCR-L and IFCR-F group (Repeated-measures ANOVA).